Electronic Prior Authorization for Prescription Drugs - Challenges and Opportunities for Reform.
作者信息
Luo Jing, Gellad Walid F
机构信息
From the Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine (J.L., W.F.G.), and the Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System (W.F.G.) - both in Pittsburgh.
出版信息
N Engl J Med. 2023 Mar 9;388(10):867-870. doi: 10.1056/NEJMp2214620. Epub 2023 Mar 4.
Abstract
摘要
相似文献
1
Electronic Prior Authorization for Prescription Drugs - Challenges and Opportunities for Reform.处方药的电子预先授权——改革的挑战与机遇
N Engl J Med. 2023 Mar 9;388(10):867-870. doi: 10.1056/NEJMp2214620. Epub 2023 Mar 4.
2
Advancing Interoperability and Prior Authorization Reform.推进互操作性和预先授权改革。
JAMA Health Forum. 2024 Jun 7;5(6):e241193. doi: 10.1001/jamahealthforum.2024.1193.
3
Electronic Prior Authorization Is Here: What You Need to Know About It.电子预先授权来了：你需要了解的相关信息。
Minn Med. 2016 Mar-Apr;99(2):44-6.
4
[Pharmaceutical prior authorization: real need or computerized antiquity?].[药品预先授权：实际需求还是计算机时代的陈旧做法？]
Aten Primaria. 2013 Feb;45(2):81-3. doi: 10.1016/j.aprim.2013.01.003.
5
Healing an ailing pharmaceutical system: prescription for reform for United States and Canada.治愈病态的制药体系：美国和加拿大的改革药方。
BMJ. 2018 May 17;361:k1039. doi: 10.1136/bmj.k1039.
6
Impact of implementing electronic prior authorization on medication filling in an electronic health record system in a large healthcare system.在大型医疗保健系统中实施电子预先授权对电子健康记录系统中药物配给的影响。
J Am Med Inform Assoc. 2021 Sep 18;28(10):2233-2240. doi: 10.1093/jamia/ocab119.
7
Refocusing Medication Prior Authorization on Its Intended Purpose.将药物预先授权重新聚焦于其预期目的。
JAMA. 2020 Feb 25;323(8):703-704. doi: 10.1001/jama.2019.21428.
8
The Consequences and Future of Prior-Authorization Reform.预先授权改革的后果与未来。
N Engl J Med. 2023 Jul 27;389(4):291-293. doi: 10.1056/NEJMp2304447. Epub 2023 Jul 22.
9
Implementation of a nonstatin prior authorization checklist for patients with hypercholesterolemia: In 2 community health care systems.为高胆固醇血症患者实施非他汀类药物预先授权清单：在2个社区医疗系统中。
J Manag Care Spec Pharm. 2025 Jul;31(7):723-728. doi: 10.18553/jmcp.2025.31.7.723.
10
Practice executives' top 10 issues to watch in 2011.2011年医疗机构管理人员需关注的十大问题
MGMA Connex. 2011 Mar;11(3):13-4.
引用本文的文献
1
Integration of Teaching of Digital Health-Driven Medical Devices in Pharmacy Education.数字健康驱动型医疗设备教学在药学教育中的整合
Pharmacy (Basel). 2025 Mar 1;13(2):35. doi: 10.3390/pharmacy13020035.
2
Accuracy of Clinical Suspicion for Rotator Cuff Tears by Orthopedic Surgeons When MRI Was Ordered on Initial Visits: Should Physical Therapy Be Mandated by Insurance Before MRI?骨科医生在初次就诊时开具MRI检查单时对肩袖撕裂的临床怀疑准确性：保险是否应在MRI检查前强制进行物理治疗？
Cureus. 2024 Jun 10;16(6):e62079. doi: 10.7759/cureus.62079. eCollection 2024 Jun.
3
Comparison of prior authorization across insurers: cross sectional evidence from Medicare Advantage.比较不同保险公司的预先授权：来自 Medicare Advantage 的横断面证据。
BMJ. 2024 Mar 7;384:e077797. doi: 10.1136/bmj-2023-077797.
4
Computer-Assisted Clinical Diagnosis and Treatment.计算机辅助临床诊断与治疗。
Curr Allergy Asthma Rep. 2023 Sep;23(9):509-517. doi: 10.1007/s11882-023-01097-8. Epub 2023 Jun 23.
本文引用的文献
1
Evaluation of the Fast Prior Authorization Technology Highway.快速预先授权技术高速公路评估。
J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1843-1847. doi: 10.1016/j.japh.2022.07.011. Epub 2022 Aug 9.
2
Out-of-Pocket Costs of Specialty Medications for Psoriasis and Psoriatic Arthritis Treatment in the Medicare Population.医疗保险人群中治疗银屑病和银屑病关节炎的特种药物自付费用。
JAMA Dermatol. 2021 Oct 1;157(10):1239-1241. doi: 10.1001/jamadermatol.2021.3616.
3
Impact of implementing electronic prior authorization on medication filling in an electronic health record system in a large healthcare system.在大型医疗保健系统中实施电子预先授权对电子健康记录系统中药物配给的影响。
J Am Med Inform Assoc. 2021 Sep 18;28(10):2233-2240. doi: 10.1093/jamia/ocab119.
4
Pharmacy Benefits Management in the Veterans Health Administration Revisited: A Decade of Advancements, 2004-2014.再次审视退伍军人健康管理局的药品福利管理：2004-2014 年的十年进展。
J Manag Care Spec Pharm. 2016 Sep;22(9):1058-63. doi: 10.18553/jmcp.2016.22.9.1058.
Zotero 插件